-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

904. Outcomes Research—Non-Malignant Conditions: Poster II

Program: Oral and Poster Abstracts
Type: Poster
Hematology Disease Topics & Pathways:
Adult, Anemias, antibodies, anticoagulant drugs, autoimmune disorders, Biological, Bleeding Disorders, Coronaviruses, CRS, Hemophilia, Leukemia, SARS-CoV-2/COVID-19, survivorship, Bleeding and Clotting, CLL, Diseases, Lymphoma (any), Non-Biological, Elderly, Hodgkin Lymphoma, platelets, Therapies, Adverse Events, Non-Hodgkin Lymphoma, Pediatric, Biological Processes, Hemoglobinopathies, Thrombosis, devices, Immune Disorders, PNH, Young Adult, Cell Lineage, Lymphoid Malignancies, Study Population, Thromboembolism, Clinically relevant, Myeloid Malignancies, Quality Improvement , Thrombotic Disorders, VTE, VWD
Sunday, December 6, 2020: 7:00 AM-3:30 PM

Harish Eswaran, MD1*, Jamie Jarmul, MD PhD2*, Amy Shaheen, MD MSc1*, David Meaux, BA2*, Tristan Long, MBA2*, Derek Saccoccio, MBA2* and Stephan Moll, MD1

1Department of Medicine, University of North Carolina School of Medicine, Chapel Hill, NC
2UNC Health, Chapel Hill, NC

Federico Germini, MD, MSc1,2*, Suzanne O'Callaghan, BA3*, Chatree Chai-Adisaksopha, MD, PhD4,5, Randall Curtis, MBA6*, Neil Frick7*, Michael B. Nichol, PhD8*, Declan Noone, MSc9,10*, Brian O'Mahony11,12*, David Page13*, Jeffrey Stonebraker14*, Mark W Skinner, JD1,15* and Alfonso Iorio, MD, PhD1,16

1Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, Canada
2Department of Medicine, McMaster University, Hamilton, Canada
3Haemophilia Foundation Australia, Melbourne, Australia
4Medicine, McMaster University, Muang, Thailand
5Division of Hematology, Department of Internal Medicine, Chiang Mai University, Chiang Mai, Thailand
6Hematology Utilization Group Study (HUGS), Walnut Creek, CA
7National Hemophilia Foundation, Berkeley
8University of Southern California, Los Angeles, CA
9Health Decisions Consultants, Dublin, Ireland
10European Haemophilia Consortium, Brussels, Belgium
11Irish Haemophilia Society, Dublin, Ireland
12Trinity College Dublin, Dublin, Ireland
13Canadian Hemophilia Society, Montreal, Canada
14North Carolina State University, Poole College of Management, Raleigh
15Institute for Policy Advancement Ltd, Washington, DC
16McMaster-Bayer Endowed Research Chair in Clinical Epidemiology of Congenital bleeding Disorders, Department of Medicine, McMaster University, Hamilton, Canada

Joanne Wu, MD, MS1*, Randall Curtis, MBA2*, Megan M. Ullman, MA, MPH3*, Judith Baker, DrPH, MHSA4*, Duc Quang Tran Jr., MD5 and Michael B. Nichol, PhD6*

1University Of Southern California, Los Angeles, CA
2Factor VIII Computing, Berkeley, CA
3Gulf States Hemophilia & Thrombophilia Center, University of Texas Health Science Center at Houston, Houston, TX
4Center for Inherited Blood Disorders, Orange, CA
5Emory University, Hemophilia of Georgia Center for Bleeding & Clotting Disorders of Emory, Atlanta, GA
6University of Southern California, Los Angeles, CA

Poy P. Theprungsirikul, MD and Sunil E. Saith, MD, MPH, FACP*

NYU Langone Health/NYU Grossman School of Medicine, New York, NY

Paul McLaughlin, MSc, MMACP1*, Cedric Hermans, MD, MRCP, PhD2, Sohaib Asghar, MSc3*, Tom Burke3*, Francis Nissen4*, Martynas Aizenas5*, Oliver Meier4*, Harpal Dhillon3* and Jamie O'Hara, MSc3,6*

1Katharine Dormandy Haemophilia Centre and Thrombosis Unit, Royal Free London NHS Foundation Trust, London, United Kingdom
2Division of Hematology, Cliniques Univ. Saint-Luc, Brussels, Belgium
3HCD Economics, Daresbury, United Kingdom
4F. Hoffmann-La Roche Ltd, Basel, Switzerland
5F. Hoffmann-La Roche Ltd, Basel, CA, Switzerland
6University of Chester, Chester, United Kingdom

Jeries Kort, MD1, Paolo F Caimi, MD2, Pingfu Fu, PhD3*, Shufen Cao3*, James Driscoll3*, Marcos de Lima, MD2 and Ehsan Malek, MD4

1University Hospitals Cleveland Medical Center, Cleveland, OH
2Adult Hematologic Malignancies & Stem Cell Transplant Section, University Hospitals Seidman Cancer Center, Cleveland, OH
3Case Western Reserve University, Cleveland, OH
4Adult Hematologic Malignancies & Stem Cell Transplant Section, Seidman Cancer Center, University Hospitals Cleveland Medical Center, Cleveland, OH

Clay T Cohen, MD1, Sarah E Sartain, MD1, Haleh Sangi-Haghpeykar, PhD2*, Kamlesh Kukreja, MD3* and Sudhen B Desai, MD3*

1Department of Pediatrics, Section of Hematology-Oncology, Baylor College of Medicine/Texas Children's Hospital, Houston, TX
2Department of Obstetrics and Gynecology, Baylor College of Medicine, Houston, TX
3Section of Interventional Radiology, Baylor College of Medicine/Texas Children's Hospital, Houston, TX

Heidi E. Kosiorek, MS1*, Amylou C. Dueck, PhD1, John Mascarenhas, MD2,3, Ruben A. Mesa, MD, FACP4, Ronald Hoffman, MD2,5 and Blake T. Langlais, MS1*

1Department of Health Sciences Research, Mayo Clinic, Scottsdale, AZ
2Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY
3Division of Hematology/Medical Oncology, Icahn School of Medicine at Mount Sinai, Tisch Cancer Institute, New York, NY
4Mays Cancer Center at UT Health San Antonio, San Antonio, TX
5Tisch Cancer Institute, Division of Hematology and Medical Oncology, Icahn School of Medicine at Mount Sinai, New York, NY

Dvora Bauman, MD1*, Adir Sommer, MD2*, Dar Noy3*, Tal Hammer3* and Shoshana Revel-Vilk, MD, MSc3,4

1Department of Obstetrics and Gynaecology, Hadassah Hebrew University Medical Center, Jerusalem, Israel
2The IDF Medical Corps, Ramat Gan, Israel
3Faculty of Medicine, Hebrew University, Jerusalem, Israel
4Pediatric Hematology/Oncology Unit, Shaare Zedek Medical Center, Jerusalem, Israel

Alexander Röth, MD1, Ulrich Jaeger, MD2, Bernd Jilma3, Wilma Barcellini4*, Anita Hill5*, Quentin Hill5*, David J. Kuter, MD6, Catherine M. Broome7*, Marc Michel8*, Sacha Sergio Zeerleder, M.D.9*, Yasutaka Ueda10*, Jaime Morales-Arias11, Jun Su11 and Sigbjørn Berentsen12*

1Department of Hematology, University Hospital Essen, University of Duisburg-Essen, Essen, Germany
2Department of Internal Medicine I, Medical University of Vienna, Vienna, AA, Austria
3Department of Clinical Pharmacology, Medical University of Vienna, Vienna, Austria
4Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy
5Department of Haematology, St James’ University Hospital, Leeds, United Kingdom
6Hematology Division, Massachusetts General Hospital, Boston, MA
7Division of Hematology, MedStar Georgetown University Hospital, Washington, D.C.
8Henri-Mondor University Hospital, Assistance Publique-Hôpitaux de Paris, UPEC, Paris, France
9Department of Hematology and Central Hematology Laboratory, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland
10Department of Hematology and Oncology, Osaka University Graduate School of Medicine, Osaka, Japan
11Sanofi, Cambridge, MA
12Department of Research and Innovation, Haugesund Hospital, Haugesund, Norway

Zachary French, MD1*, Victor Bilan, MD2*, Holleh Husseinzadeh, MD2, Douglass A. Drelich, MD2 and Ruben Rhoades, MD2

1Department of Medicine, Thomas Jefferson University, Philadelphia, PA
2Cardeza Foundation for Hematologic Research, Thomas Jefferson University, Philadelphia, PA

Diane J. Nugent, MD1*, Jamie O'Hara, MSc2,3*, Antony Martin, PhD3*, George Morgan3*, Tyler W. Buckner, MD, MSc4, Mark W Skinner, JD5,6*, Brian O'Mahony7,8*, Brendan Mulhern9*, Eileen K Sawyer, PhD10* and Nanxin Li, PhD10

1Department of Hematology, Children's Hosp. of Orange County, Orange, CA
2University of Chester, Chester, United Kingdom
3HCD Economics, Daresbury, United Kingdom
4Divisions of Hematology and Pediatric Hematology/Oncology, Hemophilia and Thrombosis Center, University of Colorado School of Medicine, Aurora, CO
5Institute for Policy Advancement Ltd, Washington, DC
6Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, Canada
7Irish Haemophilia Society, Dublin, Ireland
8Trinity College Dublin, Dublin, Ireland
9University of Technology Sydney, Sydney, NSW, Australia
10uniQure Inc., Lexington, MA

Ashwin Gupta1, Jonathan R Day, MD, PharmD2*, Michael B. Streiff, MD3, Clifford Takemoto, MD4,5*, Kyungsuk Jung, MD, MPH6*, Calvin Abro, MD6*, Eric Gehrie, MD7*, Evan Bloch, MD, MS7*, Aaron Tobian, MD, PhD7* and Ruchika Goel, MD, MPH6,7

1Vanderbilt University, Nashville, TN
2Department of Internal Medicine, University of Iowa Carver College of Medicine, Iowa City, IA
3Division of Hematology, Department of Medicine & Pathology, Johns Hopkins University School of Medicine, Baltimore, MD
4Department of Hematology, St. Jude Children's Research Hospital, Memphis, TN
5Division of Hematology, Department of Pediatrics, The Johns Hopkins University, Baltimore, MD
6Division of Hematology/Oncology, Simmons Cancer Institute, SIU School of Medicine, Springfield, IL
7Division of Transfusion Medicine, Department of Pathology, Johns Hopkins University, Baltimore, MD

Tom Burke1*, Sohaib Asghar, MSc1*, Natalia Misciattelli2*, Sharmila Kar2*, George Morgan1*, Harpal Dhillon1* and Jamie O'Hara, MSc1,3*

1HCD Economics, Daresbury, United Kingdom
2Freeline Therapeutics, London, United Kingdom
3University of Chester, Chester, United Kingdom

Olga A. Gavrilina, MD, PhD1*, Kristina Zakurdaeva2*, Vladimir I. Vorobyev, MD, PhD3, Anastasia N. Vasileva4*, Lev S. Butaev5*, Alena Sukhareva6*, Lubov Gavrilova7*, Olga Samoylova, MD8*, Maria Grishunina, MD9*, Ochsana Ochirova10*, Alina Karpova11*, Olga Panteleeva12*, Mikhail A. Kunst13*, Vasily Shuvaev, MD14,15, Anzhelika Rakhmani16*, Tatiana V. Gaponova, MD, PhD4*, Gennadiy M. Galstyan, MD, PhD4*, Vera V. Troitskaya, MD, PhD1*, Anton V. Luchkin, MD4*, Elena N. Parovichnikova, MD, PhD1* and Valery Savchenko, MD, PhD, Academician4

1National Research Center for Hematology, Moscow, Russian Federation, Moscow, Russian Federation
2RakFond, Moscow, Russia
3Hematology Department, S.P.Botkin City Hospital, Moscow, Russia
4National Research Center for Hematology, Moscow, Russian Federation
5Hematology Department, S.P.Botkin City Hospital, Moscow, Russian Federation
6S.P. Botkin City Hospital, Moscow, Russian Federation
7State Budgetary Healthcare Institution of the Republic of Mordovia "Republican Clinical Hospital No4" of the Ministry of Health of the Russian Federation, Mordovia, Russian Federation
8Regional Clinical Hospital N.A. Semashko, Nizhniy Novgorod, Russian Federation
9Regional Hospital, Nigniy Novgorod, Russian Federation
10Republican Clinical Hospital named after NA Semashko of the city of Ulan-Ude, Ulan-Ude, Russian Federation
11NA Semashko Rpublican Clinical Hospital, Ulan-Ude, Russian Federation
12Regional Clinical Hospital, Vladimir, Russian Federation
13Republican Clinical Hospital of Tatarstan, Kazan, Russian Federation
14City Clinical Hospital n.a. V.V. Veresaev of the Moscow Department of Healthcare, Moscow, Russian Federation
15Federal State Budget Institution “Russian Scientific-Research Institute of Hematology and Transfusiology of Federal Medical-Biological Agency”, St. Petersburg, Russia
16City Clinical Hospital n.a. V.V. Veresaev, Moscow, Russian Federation

Arielle L Langer, MD, MPH1, Adam Binder, MD2* and Eileen Scigliano, MD3

1Hematology Division, Brigham and Women's Hospital, Boston, MA
2Division of Hematologic Malignancies and Hematopoietic Stem Cell Transplantation, Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA
3Department of Environmental Medicine and Public Health, Icahn School of Medicine at Mount Sinai, New York, NY

Amanda Wilson1*, Ahmed Daak2 and Jun Su3

1Sanofi, Cambridge, MA
2Clinical Development, Sanofi, Waltham, MA
3Medical Affairs, Sanofi, Cambridge, MA

Ian J. Hooley, BS1*, Kathleen Maignan, NP1,2*, Alexandra Jacob1*, Angelica Medina, MSRA1*, Lauren Benderoff1*, Robert Chen, PhD1 and Scott F. Huntington, MD, MPH3

1Flatiron Health Inc, New York, NY
2Weill Cornell Medicine, New York, NY
3Yale Cancer Center, Yale University School of Medicine, New Haven, CT

*signifies non-member of ASH